Mark Blaskovich

Professor Mark Blaskovich is an antibiotic hunter and Director of Translation at the Institute for Molecular Bioscience at The University of Queensland. He is co-founder and former Director of the Centre for Superbug Solutions at IMB. A medicinal chemist with 15 years of industrial drug development experience prior to his academic career, Mark has been developing new antibiotics to treat drug resistant pathogens and using modified antibiotics to detect bacterial infections. He is a co-founder of the Community for Open Antimicrobial Drug Discovery, a global antibiotic discovery initiative, and has led a number of UQ-industry collaborations focused on antibiotic development. An inventor on eleven patent families, Mark has developed drugs in clinical trials, published more than eighty research articles, and received over $10m in grant funding. Medicinal and biomolecular chemistry

[2026] High prevalence and co-existence of SHV and CTX-M genes in extensively drug-resistant (XDR) Gram-negative bacteria isolated from hospital settings in Faisalabad District, Pakistan [2026] Newly identified antimicrobial activity of an 8-hydroxyquinoline-based ionophore against multidrug-resistant Enterococcus faecium and Staphylococcus aureus [2026] High-throughput screening assays for novel antibacterial identification: current advances and future prospects [2026] Pyrazolyl–pyridine ruthenium complexes: a new metallic line of defense against Acinetobacter baumannii [2026] Framework for evaluating explainable AI in antimicrobial drug discovery [2026] In vitro activity of robenidine analogue NCL195 against methicillin-resistant Staphylococcus pseudintermedius [2026] Synthesis and biolo